Valneva SE (VALN) Change in Acquisitions & Divestments (2024 - 2026)
Valneva SE (VALN) posted quarterly Change in Acquisitions & Divestments of $497286.0 for Q1 2026, up 100.48% on a QoQ basis from -$103.4 million in Q1 2024.
Valneva SE (VALN) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Change in Acquisitions & Divestments for 2 consecutive years, with $497286.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $497286.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $497286.0 (changed N/A YoY) and the FY2024 annual result came in at -$103.4 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments rose to $497286.0 in Q1 2026 per VALN's latest filing, from -$103.4 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for VALN reached as high as $497286.0 in Q1 2026 and fell as low as -$103.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn |
| 10 | Valneva SE | 833.33 Mn | 713.54 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 497,286.02 |
| Mar 31, 2026 | 497,286.02 |
| Mar 31, 2024 | -103.36 Mn |
| Mar 31, 2024 | -103.36 Mn |